Author:
Lee Sophie,Knox Angela,Zeng Irene S. L.,Coomarasamy Christin,Blacklock Hilary,Issa Samar
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Cancer in New Zealand: Trends and Projections (2002) Ministry of Health. http://www.moh.govt.nz/notebook/nbbooks.nsf/0/B005B6A9C2BB332DCC256C83006CF13D?opendocument
2. Lyman GH, Delgado DJ (2003) Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma. Cancer 98(11):2402–2409. doi: 10.1002/cncr.11827
3. Lyman GH, Michels SL, Reynolds MW, Barron R, Tomic KS, Yu J (2010) Risk of mortality in patients with cancer who experience febrile neutropenia. Cancer 116(23):5555–5563. doi: 10.1002/cncr.25332
4. Wolff DA, Crawford J, Dale DC, Poniewierski MS, Lyman GH, Grp AS (2004) Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy. J Clin Oncol 22(14):549S
5. Lyman GH, Morrison VA, Dale DC, Crawford J, Delgado DJ, Fridman M (2003) Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin's lymphoma receiving CHOP chemotherapy. Leuk Lymphoma 44(12):2069–2076
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献